NEW YORK (GenomeWeb News) – Genomic Health's first-quarter revenues rose 17 percent year over year, the company reported after the close of the market on Wednesday.

For the three months ended March 31, total revenues increased to $58.5 million, compared to $49.8 million for Q1 2011 and exceeding consensus analyst estimates of $56.3 million.

Product revenues, which make up most of the revenues, also increased 17 percent year over year to $57.9 million from $49.5 million, while contract revenues rose 60 percent to $563,000 from $352,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.